Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
UPenn Expert Discussion on MDS, MPN & Leukemia: Transfusion-Dependent MDS Patients, Patients Treated With Hydroxyurea for MPN, AML Pts to Treat With Ven + HMAs, Oral HMAs, Maintenance Azacitidine
Comments 0
Login to view comments.
Click here to Login
